Page 5 - Clinical Testing News Today

Researchers described the coronavirus disease 2019 (COVID-19) prevention network (CoVPN) and its contribution to clinical efficacy evaluations of COVID-19 vaccines in phase 3 trials.

/PRNewswire/ -- The "Global DNA-RNA Sample Preparation Market (2022-2027) by Type, Application, End User, and Geography, Competitive Analysis and the Impact of...

/PRNewswire/ -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry,...

/PRNewswire/ -- The "Flow Cytometry: Products, Technologies and Global Markets" report has been added to ResearchAndMarkets.coms offering. This report aims to...

Researchers at The University of Texas at Dallas and Novartis Pharmaceuticals Corp. have devised a computer-based platform for drug discovery that could make the process more effective, more efficient and less costly.

Corporate Update Call to be Held Wednesday, November 16, 2022SAN DIEGO, CA / ACCESSWIRE / November 14, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage

One of every 10 patients with appendiceal cancer carries a germline genetic variant associated with cancer predisposition, according to a study in JAMA Oncology that is the first to show inherited risk factors for this rare cancer.

Free AACC and P.A.C.E accredited webinars to earn credits for your continuing education as a medical technologist

Investigators from the departments of Neurology, Neurosurgery, Psychiatry, Medicine, and Biomedical Sciences at Cedars-Sinai have shown that an immune-suppressing drug similar to one used to treat severe COVID-19 reversed symptoms of delirium in mice whose lungs were injured during mechanical breathing assistance.

New York, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Flow Cytometry Market Size, Share & Indu